Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.

Saved in:
Bibliographic Details
Title: Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
Authors: Kaye EC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Smith J; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Zhou Y; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Bagatell R; Division of Oncology, Department of Pediatrics, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Baker JN; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Cohn SL; Department of Pediatrics, Comer Children's Hospital, University of Chicago, Chicago, Illinois, USA., Diller LR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Glade Bender JL; Department of Pediatric Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Granger MM; Hematology and Oncology Center, Cook Children's Hospital, Fort Worth, Texas, USA., Marachelian A; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California, USA., Park JR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Center for Clinical and Translational Research, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, Washington, USA.; Department of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington, USA., Rosenberg AR; Center for Clinical and Translational Research, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, Washington, USA.; Department of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington, USA.; Division of Pediatric Palliative Care, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Shusterman S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Twist CJ; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.; Division of Population Sciences' Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Source: Cancer [Cancer] 2024 Apr 01; Vol. 130 (7), pp. 1101-1111. Date of Electronic Publication: 2023 Dec 15.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0142
DOI:10.1002/cncr.35149